Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Schweighofer, N; Haudum, CW; Trummer, O; Lind, A; Kolesnik, E; Mursic, I; Schmidt, A; Scherr, D; Zirlik, A; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B.
Dp-ucMGP as a Biomarker in Sarcopenia.
Nutrients. 2022; 14(24): Doi: 10.3390/nu14245400 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Obermayer-Pietsch Barbara
Schweighofer Natascha
Co-Autor*innen der Med Uni Graz
Haudum Christoph
Kolesnik Ewald
Lind Alice Florentina
Mursic Ines
Pieber Thomas
Scherr Daniel
Schmidt Albrecht
Trummer Olivia
Verheyen Nicolas Dominik
Zirlik Andreas

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Sarcopenia is linked with an increased risk of falls, osteoporosis and mortality and is an increasing problem for healthcare systems. No satisfying biomarkers for sarcopenia diagnosis exist, connecting bone, fat and muscle. Matrix-GLA-protein (MGP) is an adipokine that regulates bone metabolism and is associated with decreased muscle strength. Associations of dp-ucMGP were analyzed in the BioPersMed cohort (58 ± 9 years), including 1022 asymptomatic subjects at moderate cardiovascular risk. Serum measurements of dp-ucMGP in 760 persons were performed with the InaKtif MGP Kit with the IDS-iSYS Multi-Discipline Automated System. DXA data (792 persons) measured with the Lunar iDXA system and physical performance data (786 persons) were available. Dp-ucMGP plasma levels correlate with sarcopenia parameters like gait speed (ρ = -0.192, p < 0.001), appendicular skeletal muscle mass (ρ = 0.102, p = 0.005) and appendicular skeletal muscle mass index (ρ = 0.112, p = 0.001). They are lower in persons with sarcopenia (p < 0.001) and higher in persons with reduced physical performance (p = 0.019). Persons in the lowest dp-ucMGP quartile have the highest risk for reduced muscle mass, decreasing with each quartile, whereas persons in the highest quartile have the highest risk of reduced muscle strength. Dp-ucMGP might be a good biomarker candidate in sarcopenia characterization.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Biomarkers - administration & dosage
Calcium-Binding Proteins - administration & dosage
Extracellular Matrix Proteins - administration & dosage
Sarcopenia - diagnosis
Middle Aged - administration & dosage
Aged - administration & dosage

Find related publications in this database (Keywords)
BioPersMed cohort
© Med Uni Graz Impressum